Pfizer Limited (NSE:PFIZER)
India · Delayed Price · Currency is INR 4,826.80
+25.50 (0.53%)
Jul 31, 2026, 3:29 PM IST
Pfizer Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 7,224 | 7,676 | 5,513 | 6,239 | 6,126 |
Depreciation & Amortization | 555.5 | 586.1 | 601 | 1,033 | 1,128 |
Other Amortization | 21.8 | 21.8 | 21.8 | 21.8 | 21.8 |
Loss (Gain) From Sale of Assets | 0.9 | -1,713 | 30.5 | -2,561 | -15.8 |
Stock-Based Compensation | 140.6 | 136.6 | 144.5 | 127 | 117.7 |
Provision & Write-off of Bad Debts | 22.3 | 13.3 | 7.8 | 17.7 | 45.7 |
Other Operating Activities | 1,300 | -581.4 | -1,299 | -984 | -1,203 |
Change in Accounts Receivable | 90.6 | -68.2 | -365.1 | -102 | -183.5 |
Change in Inventory | -252.1 | -535.6 | -160 | 218.5 | -138.6 |
Change in Accounts Payable | 633.3 | -153.1 | -502 | -381.1 | -111.9 |
Change in Other Net Operating Assets | -69.9 | 1,211 | -1,434 | -80.3 | 873.4 |
Operating Cash Flow | 9,676 | 6,598 | 2,568 | 3,557 | 6,671 |
Operating Cash Flow Growth | 46.66% | 156.87% | -27.79% | -46.68% | 56.10% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -252.3 | -281.5 | -189.3 | -649.8 | -153.1 |
Sale of Property, Plant & Equipment | 11.6 | 2 | 0.2 | 12.2 | 20.6 |
Divestitures | - | - | - | 1,805 | - |
Sale (Purchase) of Real Estate | - | 1,517 | 528.8 | - | - |
Investment in Securities | -7,146 | -3,543 | -1,093 | -2,293 | -6,125 |
Other Investing Activities | 1,770 | 1,592 | 1,290 | 765.2 | 507.3 |
Investing Cash Flow | -5,617 | -713.4 | 537 | -360.5 | -5,750 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Repaid | -381.7 | -373.1 | -410.5 | -352 | -98.9 |
Net Debt Issued (Repaid) | -381.7 | -373.1 | -410.5 | -352 | -98.9 |
Common Dividends Paid | -7,516 | -1,603 | -1,834 | -1,698 | -1,597 |
Other Financing Activities | -85 | -77.8 | -106.6 | -133.8 | -108.8 |
Financing Cash Flow | -7,983 | -2,053 | -2,351 | -3,458 | -1,805 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash Flow | -3,924 | 3,831 | 754 | -261.6 | -884.5 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 9,423 | 6,316 | 2,379 | 2,907 | 6,518 |
Free Cash Flow Growth | 49.20% | 165.48% | -18.16% | -55.40% | 59.11% |
Free Cash Flow Margin | 37.40% | 27.68% | 10.85% | 11.99% | 24.96% |
Free Cash Flow Per Share | 205.99 | 138.06 | 52.01 | 63.54 | 142.46 |
Levered Free Cash Flow | 6,500 | 5,012 | 2,334 | 3,393 | 7,385 |
Unlevered Free Cash Flow | 6,559 | 5,065 | 2,430 | 3,476 | 7,451 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 85 | 77.8 | 106.6 | 133.8 | 108.8 |
Cash Income Tax Paid | -145.3 | 1,562 | 1,538 | 3,026 | 2,259 |
Change in Working Capital | 401.9 | 454.5 | -2,461 | -344.9 | 439.4 |